Follow
Olga Volkova
Olga Volkova
senior scientist, Institute of Molecular and Cellular Biology, Novosibirsk
Verified email at mcb.nsc.ru
Title
Cited by
Cited by
Year
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
COVIDSurg Collaborative
Anaesthesia 76 (6), 748-758, 2021
590*2021
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
C COVIDSurg, C GlobalSurg
Anaesthesia 77 (1), 28-39, 2022
1092022
FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features
LV Mechetina, AM Najakshin, OY Volkova, SV Guselnikov, RZ Faizulin, ...
European journal of immunology 32 (1), 87-96, 2002
692002
A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1
SV Guselnikov, SA Ershova, LV Mechetina, AM Najakshin, OY Volkova, ...
Immunogenetics 54, 87-95, 2002
682002
Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy
E Sato, A Zaboronok, T Yamamoto, K Nakai, S Taskaev, O Volkova, ...
Journal of radiation research 59 (2), 101-107, 2018
502018
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ...
International immunology 23 (1), 43-53, 2011
462011
Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ...
Anaesthesia 76 (11), 1454-1464, 2021
452021
Analiz khozyaistvennoi deyatel'nosti pred-priyatiya [Analysis of economic activity of the enterprise]
VV Kovalev, ON Volkova
Moscow: Prospekt Publ, 2007
392007
Analysis of the economic activity of the enterprise
VV Kovalev, ON Volkova
M.: PBOYuL, 424, 2001
372001
Cloning and characterization of the human FCRL2 gene
NA Chikaev, EA Bykova, AM Najakshin, LV Mechetina, OY Volkova, ...
Genomics 85 (2), 264-272, 2005
362005
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
N Masir, M Jones, M Pozzobon, T Marafioti, OY Volkova, LV Mechetina, ...
British journal of haematology 127 (3), 335-343, 2004
342004
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ...
Cell Discovery 7 (1), 96, 2021
332021
Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia
P Glybochko, V Fomin, S Moiseev, S Avdeev, A Yavorovskiy, M Brovko, ...
Klinicheskaya farmakologiya i terapiya= Clin Pharmacol Ther 29 (3), 25, 2020
312020
Analiz hozjajstvennoj dejatel'nosti predprijatija
VV Kovalev, ON Volkova
M.: Prospekt, 2010
312010
Analiz khozyaystvennoy deyatel'nosti predpriyatiya [Analysis of the economic performance of an enterprise]
VV Kovalev, ON Volkova
M.: PBOYuL, 2000
302000
BORON-NEUTRON CAPTURE THERAPY IN RUSSIA: PRECLINICAL EVALUATION OF EFFICACY AND ERSPECTIVES OF ITS APPLICATION IN NEURO-ONCOLOGY
AA Zaboronok, VA Byvaltsev, VV Kanygin, AI Iarullina, AI Kichigin, ...
New Armenian Medical Journal 11 (1), 6-15, 2017
262017
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ...
Oncotarget 9 (10), 9021, 2018
252018
Polymer-stabilized elemental boron nanoparticles for boron neutron capture therapy: Initial irradiation experiments
A Zaboronok, P Khaptakhanova, S Uspenskii, R Bekarevich, L Mechetina, ...
Pharmaceutics 14 (4), 761, 2022
242022
Analysis of economic activity of the enterprise: Textbook
VV Kovalev, ON Volkova
Moscow: Prospect Velbi, 2010
232010
Risk factors for the early development of septic shock in patients with severe COVID-19
P Glybochko, V Fomin, S Moiseev, S Avdeev, A Yavorovskiy, M Brovko, ...
182021
The system can't perform the operation now. Try again later.
Articles 1–20